Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner

Slide Presentation from the AHRQ 2007 Annual Conference

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.



This is the text version of the slide presentation titled Using Clinical Decision Support Systems to Measure and Improve Quality of Care for Special Populations: The Elderly in the Long-term Care Setting .

Select to access the PowerPoint® presentation (670 KB).


Using Clinical Decision Support Systems to Measure and Improve Quality of Care for Special Populations: The Elderly in the Long-term Care Setting

  1. Using Clinical Decision Support Systems to Measure and Improve Quality of Care for Special Populations: The Elderly in the Long-term Care Setting
  2. It is much easier to write upon a disease than upon a remedy ....
  3. Case Study
  4. Case Study (continued)
  5. Case Study (continued)
  6. Case Study (continued)
  7. Case Study (continued)
  8. Case Study (continued)
  9. The Prescribing Casade [sic]
  10. The Prescribing Cascade (continued)
  11. The Prescribing Cascade (continued)
  12. The Prescribing Cascade (continued)
  13. Measuring the quality of prescribing to the elderly?
  14. 11 drugs that should always be avoided in the elderly
  15. Use of "Always Avoid" Drugs
  16. The Incidence and Preventability of Adverse Drug Events in Two Large Academic Long-term Care Facilities
  17. Adverse Drug Events
  18. Methods
  19. Methods (continued)
  20. Computer Generated Signals
  21. Methods (continued)
  22. Results—Event Rates
  23. Adverse Drug Events (n=815) Preventable vs Non-Preventable
  24. Adverse Drug Events by Severity (n=815)
  25. Preventability of Adverse Drug Events
  26. Error Stage for Preventable ADEs (n=338 preventable ADEs)
  27. Drug Categories
  28. Event Categories—Preventable
  29. Guiding Principles for Quality Measures
  30. Guiding Principles for Development of Quality Measures
  31. Translating Quality Measures into Clinical Decision Support
  32. CPOE with Clinical Decision Support at Baycrest Centre for Geriatric Care in Toronto, Ontario
  33. Rule Processing Warning Screen Shot
  34. Rule Processing Screen Shot Safety Alert
  35. The Big Question
  36. Blank Slide
  37. Quality Indicators for Appropriate Medication Use in Older Adults Assessing Care of Vulnerable Elders (ACOVE)
  38. Quality Indicators for Appropriate Medication Use in Older Adults Assessing Care of Vulnerable Elders (ACOVE) (continued)
  39. The Prescribing Cascade (continued)
  40. Drug 2 = Proxy for ADE
  41. Case-Control Study Design
  42. The Prescribing Cascade (continued)
  43. Case-Control Study Design (continued)
  44. Results
  45. Likelihood of L-dopa Treatment by Metoclopramide Dose
  46. Conclusion
  47. The Prescribing Cascade (continued)

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care